Ikarian Capital, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions
Manager:
Search and click to pin securities to the top
Page 1 of 8
SPDR S&P 500 ETF TRUST
Shares:320.0K
Value:$179.0M
ELI LILLY & Co
Shares:150.0K
Value:$123.9M
Tarsus Pharmaceuticals, Inc.
Shares:485.0K
Value:$24.9M
BridgeBio Pharma, Inc.
Shares:655.4K
Value:$22.7M
Crinetics Pharmaceuticals, Inc.
Shares:523.4K
Value:$17.6M
SOLENO THERAPEUTICS INC
Shares:243.0K
Value:$17.4M
CORCEPT THERAPEUTICS INC
Shares:100.0K
Value:$11.4M
Sarepta Therapeutics, Inc.
Shares:169.1K
Value:$10.8M
Blueprint Medicines Corp
Shares:113.9K
Value:$10.1M
Akero Therapeutics, Inc.
Shares:245.0K
Value:$9.9M
Avidity Biosciences, Inc.
Shares:300.0K
Value:$8.9M
ALNYLAM PHARMACEUTICALS, INC.
Shares:31.6K
Value:$8.5M
Biohaven Ltd.
Shares:348.2K
Value:$8.4M
TG THERAPEUTICS, INC.
Shares:210.1K
Value:$8.3M
Verona Pharma plc
Shares:130.0K
Value:$8.3M
Vaxcyte, Inc.
Shares:200.0K
Value:$7.6M
TRUPANION, INC.
Shares:200.0K
Value:$7.5M
Arcellx, Inc.
Shares:111.6K
Value:$7.3M
Vir Biotechnology, Inc.
Shares:1.1M
Value:$6.9M
Immunovant, Inc.
Shares:400.0K
Value:$6.8M